Psychiatry & Neurology, Clinical Neurophysiology · Burlington, MA
NPI
1043486632
Since 2008
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
41 Mall Rd, Lahey Clinic Department of Neurology
Burlington, MA, 01805
Phone (781) 744-8630
Groups this clinician bills Medicare through
Medicare paid, 2024
$80K
893 services
Medicare patients, 2024
404
Average age 71
Drug cost, 2024
$504K
3,248 prescriptions
Company payments, 2024
$99.77
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ritu Bagla was code 99215 (office e&m - established), 238 times for 172 patients. In total Ritu Bagla billed 893 services in 26 codes, and Medicare paid $80K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-05-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 238 | 172 | $109.51 | $26K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 166 | 134 | $14.01 | $2,326 |
| 95720 Neurologic | Facility | 143 | 62 | $176.66 | $25K |
| 95816 Neurologic | Facility | 60 | 58 | $44.47 | $2,668 |
| 95819 Neurologic | Facility | 45 | 40 | $44.34 | $1,995 |
| 95813 Neurologic | Facility | 42 | 42 | $68.01 | $2,856 |
| 99215 Office E&M - Established | Office | 29 | 21 | $154.33 | $4,476 |
| 99232 Hospital E&M - Subsequent | Facility | 27 | 13 | $67.30 | $1,817 |
| 99222 Hospital E&M - Initial | Facility | 26 | 24 | $107.32 | $2,790 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 24 | 19 | $14.18 | $340 |
| 95718 Neurologic | Facility | 21 | 20 | $114.71 | $2,409 |
| 99239 Hospital Discharge Management | Facility | 11 | 11 | $91.12 | $1,002 |
By year: 2022 $69K for 616 services; 2023 $79K for 678 services; 2024 $80K for 893 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ritu Bagla prescribed most often to Medicare patients was Lamotrigine, with 549 prescriptions and refills. In total Ritu Bagla wrote 3,248 Medicare prescriptions that cost $504K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lamotrigine Generic | 549 | 854 | 70 | $11K |
| Levetiracetam Generic | 507 | 963 | 104 | $20K |
| Lacosamide Generic | 267 | 359 | 43 | $37K |
| Topiramate Generic | 221 | 301 | 26 | $3,896 |
| Phenobarbital Generic | 175 | 289 | 23 | $5,549 |
| Divalproex Sodium Generic | 139 | 173 | 20 | $6,623 |
| Gabapentin Generic | 100 | 167 | 20 | $6,612 |
| Clobazam Generic | 95 | 97 | Under 11 | $18K |
| Carbamazepine Generic | 75 | 126 | 12 | $4,846 |
| Phenytoin Sodium Extended Generic | 69 | 143 | 13 | $2,086 |
| Xcopri Cenobamate | 64 | 80 | Under 11 | $117K |
| Divalproex Sodium Er Divalproex Sodium | 53 | 71 | Under 11 | $2,184 |
| Dilantin Phenytoin Sodium Extended | 47 | 134 | 14 | $24K |
| Citalopram Hbr Citalopram Hydrobromide | 46 | 102 | Under 11 | $273 |
| Phenytoin Generic | 43 | 51 | Under 11 | $1,020 |
Brand drugs: 266 claims; generic drugs: 2,807 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Ritu Bagla $99.77 ($99.77 in general payments such as food, travel and fees) from 1 company. The largest payer was SK Life Science, Inc. with $99.77.
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 1 | $99.77 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.